Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Schlessinger

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Nature Genetics|February 28, 2006
Mutations in different components of FGF signaling in LADD syndromeEdyta Rohmann, Han G Brunner, Hülya Kayserili, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2014
Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinomaC Christofer Juhlin, Gerald Goh, James M Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial CancerElena Bonazzoli, Federica Predolini, Emiliano Cocco, et al.
Cancer Discovery|October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerScott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Gynecologic Oncology|March 23, 2023
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitorBlair McNamara, Justin Harold, Diego Manavella, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesNatasha I Edman, Rachel L Redler, Ashish Phal, et al.
Nature Genetics|July 31, 2012
Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaMichael Krauthammer, Yong Kong, Byung Hak Ha, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaSiming Zhao, Murim Choi, John D Overton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityJames Tsai, John T Lee, Weiru Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervixStefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Nature Genetics|February 28, 2006
Mutations in different components of FGF signaling in LADD syndromeEdyta Rohmann, Han G Brunner, Hülya Kayserili, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2014
Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinomaC Christofer Juhlin, Gerald Goh, James M Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial CancerElena Bonazzoli, Federica Predolini, Emiliano Cocco, et al.
Cancer Discovery|October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerScott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Gynecologic Oncology|March 23, 2023
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitorBlair McNamara, Justin Harold, Diego Manavella, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesNatasha I Edman, Rachel L Redler, Ashish Phal, et al.
Nature Genetics|July 31, 2012
Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaMichael Krauthammer, Yong Kong, Byung Hak Ha, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaSiming Zhao, Murim Choi, John D Overton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityJames Tsai, John T Lee, Weiru Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervixStefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, et al.
Pageof 13